MK 677
MK-677, also known as Ibutamoren, is a non-peptide, orally active ghrelin receptor agonist that stimulates the pituitary gland to release Growth Hormone and subsequently elevates IGF-1 levels — replicating the GH-stimulating benefits of injectable GHRPs in a convenient oral daily capsule. It is unique among GH-stimulating compounds in that it does not suppress endogenous GH production or require injection.
The GH and IGF-1 elevation produced by MK-677 supports lean muscle mass increases, accelerated recovery from training and injury, significant improvements in sleep quality and depth, enhanced fat metabolism, and improved skin, hair, and joint health over extended use periods. Its effects build progressively with consistent use, with users typically noting the most significant benefits after 8 to 16 weeks of daily administration.
MK-677 does not suppress the HPG axis and does not require post-cycle therapy, as its action is entirely through the GH axis rather than androgen receptors. It is commonly used year-round at 12.5 to 25 mg per day for long-term GH and IGF-1 support, and stacks exceptionally well with LGD-4033 or RAD-140 during bulking phases for comprehensive anabolic and recovery synergy.
| Details | Information |
|---|---|
| API | Ibutamoren (MK-677) |
| Strength | 25 mg |
| Format | Oral Capsules |
| Quantity | 30 Capsules |
| Category | GH Secretagogue / Oral |
| Usage | Oral Use Only |
Disclaimer: Above mentioned information is for educational and reference purposes only. Consult a registered healthcare professional for a proper course of medication. These statements have not been evaluated by the Food and Drug Administration. This product shall only be available on a prescription from a registered healthcare professional.
Frequently Asked Questions
What is MK 677?
What is MK 677 commonly associated with?
How is MK 677 typically used?
Are there risks associated with MK 677?
Can MK 677 be used without medical supervision?
Is MK 677 suitable for everyone?







Reviews
There are no reviews yet.